ABSTRACT-Exposure of liver homogenates to an in vitro tert-butyl hydroperoxide challenge can be used as a means for measuring the reduced glutathione regeneration capacity (GRC) of hepatic tissues. Pretreatment of rats with a lignan-enriched extract of Fructus Schisandrae (FS) caused a moderate enhancement of hepatic GRC in control rats, but the GRC enhancing effect of FS pretreatment on hepatic tissues was greatly exaggerated after CC14 challenge. This in vitro bioassay can be used for investigating the hepatic GRC promoting action of orally active agents.
general mechanism of tissue damage in a variety of pathological conditions, including inflammation, cancer and diseases affecting a number of organs including the liver (1) . Since reduced glutathione (GSH)-mediated reactions are the most important cellular antioxidant mechanism for dealing with oxygen toxicity in aerobic organisms (2) , alterations in the functioning of the GSH antioxidant system may play a critical role in influencing tissue susceptibility to pathological changes caused by increased oxidative stress. This also suggests that conditions associated with oxidative stress may be ameliorated by therapy that increases the cellular GSH level or the cellular capacity for GSH synthesis and regeneration (3) . Since the use of cysteine or its precursors for maintaining the cellular GSH level through de novo synthesis may have untoward consequences due to its pro-oxidant properties (4) , much attention is, therefore, currently focussed on exploring alternative agents for enhancing tissue GSH antioxidant status. In this connection, we have recently demonstrated the beneficial effect of a lignan-enriched extract of Fructus Schisandrae (FS), the fruit of Schisandra chinensis, on hepatic GSH status, as evidenced by a significant increase in hepatic GSH level and a decrease in the susceptibility of hepatic tissue homogenates to peroxide-induced GSH depletion in control and carbon tetrachloride (CC14)-treated rats (5) . Since the ability to regenerate GSH seems to be more important than basal levels of GSH in protecting tissues from damage under conditions of oxidative stress (6), we have, therefore, examined whether FS extract treatment can enhance the regeneration of hepatic GSH, using an in vitro assay system. N-Acetylcysteine, a known GSH enhancing agent, was also studied for comparison.
Adult female Sprague-Dawley rats (200-250 g; Animal House, The Chinese University of Hong Kong, Hong Kong) were maintained at 221C with a 12/12 hr dark/light cycle and allowed water and food ad libitum. They were treated intragastrically with FS extract (prepared from the fruits of Schisandra chinensis as described in (6) ) or Nacetylcysteine (NAC) (Sigma Chemical Co., St. Louis, MO, USA) at a daily dose of 1.6 g/kg or 80 mg/kg, respectively, for 3 days. Animals were orally administered with CC14 (1101o (v/v) in olive oil) at a dose of 1.0 ml CC14/kg 24 hr after the last dosing. All control animals were given the vehicle only (i.e., olive oil). Twenty-four hours after the CC14 challenge, liver tissue and heparinized blood samples were taken from etheranesthetized animals that were then sacrificed by cardiac excision. Liver homogenates (10% (w/v) in 50 mM Tris-0.1 mM EDTA, pH 7.6) were prepared using a tissue disintegrator (two 10-sec bursts at 135,000 rpm). For the measurement of GSH regeneration capacity (GRC), one 2-ml aliquot of liver homogenate was combined with an equal volume of tert-butyl hydroperoxide (Sigma Chemical Co.) solution at 0.1 mM final concentration in isotonic saline. The reaction mixture was incubated in an ice bath for a period of 10 min that was then followed by a 50-min incubation at 371C. Following increasing periods of incubation (ranging from 15 sec to 60 min), a 0.4-m1 aliquot of the reaction mixture was taken at each time interval and combined with 0.1 ml cold trichloroacetic acid (TCA) (25%, w/v) for terminating the reaction. After centrifugation (10 min at 2,500 x g, 4°C), the supernatants were analyzed spectrophotometrically for acid-soluble free sulfhydryl group content, an indirect measure of GSH, using 5,5'-dithio-bis(2-nitrobenzoic acid) (7) . The basal GSH level of liver homogenate was measured using superantant prepared from a mixture containing 0.2 ml liver homogenate, 0.2 ml isotonic saline and 0.1 ml TCA solution. As demonstrated here for the first time, GRC was estimated from a graph of plotting the % control of the GSH level (with respect to basal level) against the incubation time (up to 60 min) by computing the area under the curve (AUC). Using cytosolic fractions prepared by diluting (1:3, v/v) liver homogenate (10%, w/v) with the homogenizing buffer and centrifuging at 80,000 x g, 41C for 30 min, hepatic glucose-6-phosphate dehydrogenase (G6PDH) and glutathione reductase (GRD) activities were measured as previously described (5). Plasma alanine aminotransferase (ALT) activity was measured by an assay kit from Sigma Chemical Co. tert-Butyl hydroperoxide (BHP) is commonly used as a pharmacological tool for investigating the mechanism involved in oxidative tissue damage including that of the liver (8) . When it is exposed to tissues, BHP is decomposed by the catalytic action of Se-glutathione peroxidase, with resultant formation of tert-butyl alcohol and a concomitant oxidation of GSH to oxidized glutathione (GSSG) (8, 9) . As shown in Fig. 1 , when liver homogenates prepared from control rats were challenged by BHP at a final concentration of 0.1 mM, an abrupt depletion of GSH (down to 35% of basal level) during the initial 15 sec of incubation was observed, which was followed by a sustained regeneration of GSH level (back to 63% of the basal level) at 20 min after initiation of the reaction. The GSH level then gradually declined and reached a minimum level (8% of basal level) after 50 min of incubation. While liver homogenates prepared from rats pretreated with FS extract showed an augmented GSH regeneration following the initial depletion induced by BHP, NAC pretreatment only slowed down the oxidation of GSH after the regenerative phase when compared with that of the unpretreated control (Fig. la) . Under conditions of oxidative stress as in the case of BHP challenge, the G6PDH-controlled hexose monophosphate shunt is activated so as to generate NADPH used for the GRD-catalyzed regeneration of GSH from GSSG (6). Since GSSG can directly regulate the activity of G6PDH (10), the activation of G6PDH in liver homogenates after exposure to BHP is probably caused by the increased formation of GSSG arising from the Se-glutathione peroxidase-catalyzed decomposition of BHP (9) . Under the present in vitro experimental conditions, it appeared that the metabolic support for NADPH synthesis could not persist for sustaining the regeneration of GSH. As a result, the GSH level of liver homogenate was gradually depleted after the prevailing rate of GSH oxidation had surpassed that of GSH regeneration. When liver homogenates prepared from CC14-treated rats were challenged by BHP, the regeneration of GSH was greatly depressed (Fig. lb) . However, the beneficial effect of FS and NAC pretreatment on GSH regeneration became more evident after CC14 challenge (Fig. lb) .
Given the biphasic mode of BHP-induced alterations in GSH levels, one way to measure the GSH regeneration capacity (GRC) of liver homogenates is the estimation of AUC from a graph of plotting the percentage of the basal GSH level (°1o control) against the incubation time (see Fig. 2 ). As shown in Table 1 , hepatic GRC was drastically reduced by 72% in the control rats after the CC14 challenge. Although FS pretreatment only slightly increased hepatic GRC in the control rats, it significantly boosted hepatic GRC in the CC14-treated rats up to a level higher than that of the non-CCl4 treated rats (Fig. 2 , Table 1 ). Rats pretreated with an optimal dose of NAC produced a similar effect on hepatic GRC, but to a smaller degree when compared with that of FS ( Table 1) . The GRC promoting effect of both FS and NAC pretreatment was paralleled by a significant hepatoprotective action against CC14 toxicity, as indicated by the precipitous drop in plasma ALT activities when compared with the CC14-treated control ( Table 1 ). The involvement of free radical-mediated oxidative processes in the development of CC14 hepatotoxicity is well-established (11) . GSH is a crucial determinant of tissue susceptibility to oxidative damage, and the depletion of hepatic GSH content has been shown to be associated with an enhanced toxicity to chemicals including CC14 (12, 13) . Our finding of the hepatoprotection afforded by pretreatment with NAC, a precursor for GSH synthesis, indicates that sustaining of the hepatic GSH level is an important factor involved in protecting against CC14 hepatotoxicity. More important, as indicated here by our data, is the ability of the hepatic GSH antioxidant system to regenerate GSH under conditions of increased oxidative stress. Using the present in vitro bioassay system, we were able to quantitatively define the GRC promoting effect of a lignan-enriched extract of FS. Since the hepatic GSH level is highly regulated, it is difficult to increase hepatic GSH beyond its physiological maximum concentration by supplementation with GSH precursors unless hepatic GSH stores have been depleted previously with xenobiotics (14) . In this regard, the GRC promoting effect of FS pretreatment, though being marginally detectable in control animals, was greatly exaggerated in CC14-treated rats (Table 1) . When the activities of two key enzymes responsible for hepatic GSH regeneration were examined, it was found that a significant increase in hepatic GRD activity was associated with the enhancement of GRC in FS pretreated rats with or without CC14 challenge ( Table 1) . The observation of GRC impairment in C04-treated rats regardless of elevated hepatic G6PDH activity indicates that the activity of G6PDH is not limiting in the production of NADPH under the present experimental conditions. Alternatively, the formation of glucose-6-phosphate, a substrate for G6PDH, may be hampered by an impairment in the functioning of hexokinase, possibly through reactive CC14 metabolites-mediated enzyme inactivation (15) . This postulation is consistent with the observation that hepatic GRC could be increased by adding exogenous NADPH in the incubation mixture containing liver homogenates prepared from CC14-treated rats (data not shown). Given the parallelism between the enhancement of hepatic GRC and hepatoprotection against CC14 toxicity, the ability of FS and NAC pretreatment to promote hepatic GRC measured in vitro may actually reflect an analogous action in vivo. The maintenance of hepatic GSH level both in vivo and in vitro is likely mediated by the promotion of regeneration and/or synthesis of GSH following FS or NAC treatment. It should be noted, however, that the enhancement of hepatic GRC in vitro may only be a manifestation of hepatoprotection against CC14 toxicity caused by actions other than the promotion of hepatic GRC in vivo. While a-tocopherol acetate, a hepatoprotectant against CC14 toxicity, only enhanced hepatic GRC in CC14-treated rats (data not shown), FS promoted hepatic GRC in both the control and CC14-treated animals. Our finding therefore strongly suggests the involvement of GSH regeneration-related processes in the hepatoprotection afforded by FS pretreatment. In conclusion, results obtained from the present study suggest the use of a bioassay system comprising an in vivo model of CC14 hepatotoxicity and an in vitro assay of BHP-induced GSH depletion for investigating the hepatic GRC promoting action of orally active agents.
